Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02554383 · ClinicalTrials.gov registry record · Phase 3
Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?
A Phase 3 study, sponsored by Nader Shaikh.
- Completed
- Registry status
- Phase 3
- Development phase
- 515
- Enrollment target
NCT02554383 is a Phase 3 study that has completed, run by Nader Shaikh. The registered enrollment target is 515 participants.
The verdict
NCT02554383, a Phase 3 study, has completed, sponsored by Nader Shaikh.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 515 participants
- Enrollment target
Study Summary
The objective of this trial is to determine whether certain subgroups of children with acute sinusitis exist in whom antibiotic therapy can be appropriately withheld.
Interventions
- DRUG Placebo
- DRUG Amoxicillin-clavulanate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 515 participants |
| Start Date | 2016-02 |
| Est. Completion | 2023-03-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02554383
The ClinicalTrials.gov registry entry for NCT02554383 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 515 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nader Shaikh, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02554383 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02554383 about?
NCT02554383 is a clinical study titled "Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?". The objective of this trial is to determine whether certain subgroups of children with acute sinusitis exist in whom antibiotic therapy can be appropriately withheld.
What is the current status of trial NCT02554383?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 515 participants. The study started on 2016-02. Estimated completion is 2023-03-09.
What interventions are being tested in trial NCT02554383?
The interventions under investigation include: Placebo (DRUG), Amoxicillin-clavulanate (DRUG).
Who is sponsoring clinical trial NCT02554383?
This trial is sponsored by Nader Shaikh, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.